Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: A case-control study

Oncology Reports

Volumn 19, Issue 1, 2008, Pages 217-222

  Chang, Kai Ping ^a,b   Hao, Sheng Po ^a   Tsang, Ngan Ming ^a   Chang, Yu Liang ^a   Cheng, Ming Huei ^a   Liu, Chun Ting ^a   Lee, Yun Shien ^a,c   Tsai, Chia Lung ^a   Lee, Ta Jen ^a   Wang, Tzu Hao ^a   Tsai, Chi Neu ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c MING CHUAN UNIVERSITY   (Taiwan)

Author keywords

DNA methyltransferase 3B; Nasopharyngeal carcinoma; Single nucleotide polymorphism

Indexed keywords

COMPLEMENTARY DNA; CYTOSINE; DNA METHYLTRANSFERASE 3B; THYMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE OVEREXPRESSION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TUMOR SUPPRESSOR GENE;

EID: 38749097781     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.1.217     Document Type: Article

References (31)

1. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet 9: 2395-2402, 2000.
2. Momparler RL and Bovenzi V: DNA methylation and cancer. J Cell Physiol 183: 145-154, 2000.
3. Robertson KD: DNA methylation and human disease. Nat Rev Genet 6: 597-610, 2005.
4. Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC and Jiang SW: Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol 96: 531-538, 2005.
5. Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT and Wang YC: Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. Lung Cancer 55: 205-213, 2007.
6. Yakushiji T, Uzawa K, Shibahara T, Noma H and Tanzawa H: Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 22: 1201-1207, 2003.
7. Girault I, Tozlu S, Lidereau R and Bieche I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9: 4415-4422, 2003.
8. Lee SJ, Jeon HS, Jang JS, et al: DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26: 403-409, 2005.
9. Li Y, Dai Y, Wu SL, Pei P, Cao XH and Pu DF: The C46359T polymorphism of DNMT3B promoter gene and pathogenesis of acute leukemia. Zhonghua Nei Ke Za Zhi 44: 588-591, 2005.
10. Shen H, Wang L, Spitz MR, Hong WK, Mao L and Wei Q: A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 62: 4992-4995, 2002.
11. Singal R, Das PM, Manoharan M, Reis IM and Schlesselman JJ: Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. Oncol Rep 14: 569-573, 2005.
12. Aung PP, Matsumura S, Kuraoka K, et al: No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 14: 1151-1154, 2005.
13. Montgomery KG, Liu MC, Eccles DM and Campbell IG: The DNMT3B C->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 6: 390-394, 2004.
14. Wang YM, Wang R, Wen DG, et al: Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. World J Gastroenterol 11: 3623-3627, 2005.
15. Hsu MM and Tu SM: Nasopharyngeal carcinoma in Taiwan. Clinical manifestations and results of therapy. Cancer 52: 362-368, 1983.
16. Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet 365: 2041-2054, 2005.
17. Tan SH, Ida H, Goh BC, Hsieh W, Lob M and Ito Y: Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. Anticancer Res 26: 4287-4292, 2006.
18. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ and Huang DP: Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8: 131-137, 2002.
19. Lo KW, Kwong J, Hui AB, et al: High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61: 3877-3881, 2001.
20. Tsai CL, Li HP, Lu YJ, et al: Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 66: 11668-11676, 2006.
21. Tsai CN, Tsai CL, Tse KP, Chang HY and Chang YS: The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 99: 10084-10089, 2002.
22. Sun X, Ding H, Hung K and Guo B: A new MALDI-TOF based mini-sequencing assay for genotyping of SNPs. Nucleic Acids Res 28: E68, 2000.
23. Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G and Jones PA: Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res 2: 62-72, 2004.
24. Liao HK, Su YN, Kao HY, Hung CC, Wang HT and Chen YJ: Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ ionization mass spectrometry assay for beta-thalassemia mutations. J Hum Genet 50: 139-150, 2005.
25. Stanssens P, Zabeau M, Meersseman G, et al: High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res 14: 126-133, 2004.
26. Chang KP, Hao SP, Liu CT, et al: Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: A case-control study. Oral Oncol 43: 345-351, 2007.
27. Bieche I, Tozlu S, Girault I and Lidereau R: Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Mol Cancer 3: 37, 2004.
28. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H and Hirohashi S: Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. ProcNatl Acad Sci USA 99: 10060-10065, 2002.
29. Wang L, Wang J, Sun S, et al: A novel DNMT3D subfamily, ΔDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. Int J Oncol 29: 201-207, 2006.
30. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y and Yuasa Y: Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 385: 557-564, 2005.
31. Yanagisawa Y, Ito E, Yuasa Y and Maruyama K: The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim Biophys Acta 1577: 457-465, 2002.